Sanofi has received two separate bids from private equity firms for its consumer health unit, which could be valued at 15 ...

Under an agreement with the state, the popular flu and cold medication will be manufactured in Wilson County by the end of ...

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...

The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the ...

Through an alliance announced last July, Pfizer has partnered with venture firm Flagship Pioneering to develop 10 new drug ...

Pfizer's stock underperformed its healthcare peers since PFE topped out in late July 2024. Click here to find out why I ...

Health Canada recently asked provinces and territories to get rid of their older COVID-19 vaccines to ensure the most current ...

We recently compiled a list of the 8 Best Wide Moat Stocks to Buy According to Analysts. In this article, we are going to ...

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

The company's software allows organizations to manage, track, and automate workflows through a unified platform. Smartsheet ...

Comirnaty targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 subvariant ...